| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |